CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
about
The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patientsPredictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study.Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients.Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.Prognostic value of endocrine treatment-related symptoms in patients with breast cancer: a meta-analysis.Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer."Just Wear Dark Underpants Mainly": Learning from Adolescents' and Young Adults' Experiences with Early Discontinuation of the Contraceptive Implant.
P2860
Q30234511-0DFC46C4-6D1E-43F2-A1D0-70426310D404Q35974459-7BEC96FB-CD63-481C-91D8-861F8DE33EFCQ38295718-95E070AA-8033-45CB-8F4C-CF22F7ADFB6CQ38737784-7AF21946-A47E-4A1B-B3EB-419AF41474A8Q38739248-A3F891FA-711E-4DBA-9E12-3E9515D96213Q38963111-81DF58ED-5A49-4569-88EE-0C799D02CA35Q48179087-227319EF-4238-46D8-AF40-638527662C8BQ50462957-14CCC1D8-4F00-4F0B-A678-A31BD23FC609
P2860
CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@ast
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@en
type
label
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@ast
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@en
prefLabel
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@ast
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@en
P2093
P2860
P1476
CYP19A1 polymorphisms and clin ...... cancer in the BIG 1-98 trial.
@en
P2093
Alan S Coates
Aron Goldhirsch
Beat Thürlimann
Birgitte Bruun Rasmussen
Bradley Long
Brandon Young
Brian Leyland-Jones
Henrik J Ditzel
Isabelle Treilleux
James M Rae
P2860
P2888
P304
P356
10.1007/S10549-015-3378-3
P407
P577
2015-05-03T00:00:00Z